Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-24-022413

Co-Chief Executive Officer acquired 126,667 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cohen Joshua B Co-Chief Executive Officer 2024-02-26 Grant or award +126,667 3,027,137 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cohen Joshua B Co-Chief Executive Officer 2024-02-26 Grant or award · Stock Option (right to buy) +190,000 190,000 D: show line 2 in the form
Loading xslF345X05/ownership.xml…